Decibel Therapeutics, Inc.
Regeneron is dedicated to moving science to medicine, aiming to transform the lives of people with serious diseases through innovative biopharmaceutical solutions. The company emphasizes pioneering a new era in biopharmaceutical innovation, leveraging cutting-edge science and technology to develop life-changing medicines. Regeneron is committed to responsible business practices, fostering scientific talent, and making a significant impact in cancer research, genetics, immunology, and other medical fields. Their efforts include extensive research, technological innovation, collaborations, and a focus on genetic medicines, antibody technologies, personalized treatments, and addressing global health challenges.
Industries
Nr. of Employees
medium (51-250)
Decibel Therapeutics, Inc.
Cambridge, Massachusetts, United States, North America
Products
Biologics and Genetic Medicines
Innovative biologic and genetic medicines for serious diseases.
Antibody Technologies
Development of monoclonal, bispecific, and other antibody-based therapies.
Gene Editing and Cell Therapies
Advanced therapies including gene editing and cell-based treatments.
Personalized Medicine Approaches
Tailoring treatments based on genetic and molecular profiles.
Biologics and Genetic Medicines
Innovative biologic and genetic medicines for serious diseases.
Antibody Technologies
Development of monoclonal, bispecific, and other antibody-based therapies.
Gene Editing and Cell Therapies
Advanced therapies including gene editing and cell-based treatments.
Personalized Medicine Approaches
Tailoring treatments based on genetic and molecular profiles.
Services
Research and Development
Regeneron invests heavily in research and development to discover new medicines and therapies.
Manufacturing
The company manufactures investigational and approved medicines with high quality and efficiency.
Genetic and Genomic Research
Utilizing large-scale human genomics research to understand genetic drivers of health and disease.
Clinical Trials
Conducting clinical trials to test the safety and efficacy of new medicines.
Collaborations and Partnerships
Partnering with academic institutions, biotech, and other organizations to accelerate innovation.
Research and Development
Regeneron invests heavily in research and development to discover new medicines and therapies.
Manufacturing
The company manufactures investigational and approved medicines with high quality and efficiency.
Genetic and Genomic Research
Utilizing large-scale human genomics research to understand genetic drivers of health and disease.
Clinical Trials
Conducting clinical trials to test the safety and efficacy of new medicines.
Collaborations and Partnerships
Partnering with academic institutions, biotech, and other organizations to accelerate innovation.